论文部分内容阅读
There is an increased prevalence of dementia in Asia due to the growing aging population that outnumbers the rest of the world.This rising prevalence of dementia has caused a high global demand for cognitive enhancers or brain health products.Pharmacological approaches or "smart drugs" developed for cognitive enhancement have been known to be riddled with adverse side effects and conflicting outcome.Owing to the lack of an effective pharmacological approach there is an emerging interest in developing neutraceuticals and therapeutic nutritional products to manage or improve dementia.